These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2507740)

  • 1. Synthesis and characterization of new chromium(III), vanadium(IV), and titanium(III) complexes with biologically active isonicotinic acid hydrazide.
    Pin Y; Zhang XP
    J Inorg Biochem; 1989 Sep; 37(1):61-8. PubMed ID: 2507740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of chemical bonding, physical and biological effect of metformin drug as an organized medicine for diabetes patients with chromium(III) and vanadium(IV) ions.
    Adam AM; Sharshar T; Mohamed MA; Ibrahim OB; Refat MS
    Spectrochim Acta A Mol Biomol Spectrosc; 2015; 149():323-32. PubMed ID: 25965516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on chemistry, spectroscopy and antioxidant activities of chromium(III)-hydrazide complexes.
    Shamshad B; Jamal RA; Ashiq U; Mahrooof-Tahir M; Shaikh Z; Sultan S; Khan KM
    Med Chem; 2015; 11(8):798-806. PubMed ID: 25827721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and characterization of chromium(III) Schiff base complexes: antimicrobial activity and its electrocatalytic sensing ability of catechol.
    Kumar SP; Suresh R; Giribabu K; Manigandan R; Munusamy S; Muthamizh S; Narayanan V
    Spectrochim Acta A Mol Biomol Spectrosc; 2015 Mar; 139():431-41. PubMed ID: 25576940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA interaction, antimicrobial, anticancer activities and molecular docking study of some new VO(II), Cr(III), Mn(II) and Ni(II) mononuclear chelates encompassing quaridentate imine ligand.
    Abdel-Rahman LH; Abu-Dief AM; Aboelez MO; Hassan Abdel-Mawgoud AA
    J Photochem Photobiol B; 2017 May; 170():271-285. PubMed ID: 28456118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Template synthesis and spectral studies on mononuclear complexes of chromium(III) and manganese(II) with tetradentate N4 donor macrocycles.
    Kumar R; Masih I; Fahmi N
    Spectrochim Acta A Mol Biomol Spectrosc; 2013 Jan; 101():100-6. PubMed ID: 23099166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and reactivity of the oxovanadium(IV) complexes of two N-O donors and potentiation of the antituberculosis activity of one of them on chelation to metal ions: Part IV.
    Maiti A; Ghosh S
    J Inorg Biochem; 1989 Jun; 36(2):131-9. PubMed ID: 2547895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroxyquinoline derived vanadium(IV and V) and copper(II) complexes as potential anti-tuberculosis and anti-tumor agents.
    Correia I; Adão P; Roy S; Wahba M; Matos C; Maurya MR; Marques F; Pavan FR; Leite CQF; Avecilla F; Costa Pessoa J
    J Inorg Biochem; 2014 Dec; 141():83-93. PubMed ID: 25226436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitubercular activity of Ru (II) isoniazid complexes.
    Aguiar Id; Tavares A; Roveda AC; da Silva AC; Marino LB; Lopes ÉO; Pavan FR; Lopes LG; Franco DW
    Eur J Pharm Sci; 2015 Apr; 70():45-54. PubMed ID: 25638418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligational behaviour of lomefloxacin drug towards Cr(III), Mn(II), Fe(III), Co(II), Ni(II), Cu(II), Zn(II), Th(IV) and UO(2)(VI) ions: synthesis, structural characterization and biological activity studies.
    Abd el-Halim HF; Mohamed GG; el-Dessouky MM; Mahmoud WH
    Spectrochim Acta A Mol Biomol Spectrosc; 2011 Nov; 82(1):8-19. PubMed ID: 21855402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quinonoid and phenazine compounds: synthesis and evaluation against H37Rv, rifampicin and isoniazid-resistance strains of Mycobacterium tuberculosis.
    Carneiro PF; Pinto Mdo C; Coelho TS; Cavalcanti BC; Pessoa C; de Simone CA; Nunes IK; de Oliveira NM; de Almeida RG; Pinto AV; de Moura KC; da Silva PA; da Silva Júnior EN
    Eur J Med Chem; 2011 Sep; 46(9):4521-9. PubMed ID: 21820768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and characterization of vanadium(IV) complexes with cis-inositol in aqueous solution and in the solid-state.
    Morgenstern B; Kutzky B; Neis C; Stucky S; Hegetschweiler K; Garribba E; Micera G
    Inorg Chem; 2007 May; 46(10):3903-15. PubMed ID: 17419616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mode of action and quantitative structure-activity correlations of tuberculostatic drugs of the isonicotinic acid hydrazide type.
    Seydel JK; Schaper KJ; Wempe E; Cordes HP
    J Med Chem; 1976 Apr; 19(4):483-92. PubMed ID: 817022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Model investigations for vanadium-protein interactions: vanadium(III) compounds with dipeptides and their oxovanadium(IV) analogues.
    Tasiopoulos AJ; Tolis EJ; Tsangaris JM; Evangelou A; Woollins D; Slawin AM; Pessoa C; Correia I; Kabanos TA
    J Biol Inorg Chem; 2002 Apr; 7(4-5):363-74. PubMed ID: 11941494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cr(III), Fe(III) and Co(III) complexes of tetradentate (ONNO) Schiff base ligands: synthesis, characterization, properties and biological activity.
    Keskioğlu E; Gündüzalp AB; Cete S; Hamurcu F; Erk B
    Spectrochim Acta A Mol Biomol Spectrosc; 2008 Aug; 70(3):634-40. PubMed ID: 17904895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structure, complexation, spectroscopic characterization and antimicrobial evaluation of 3,4-dihydroxybenzylidene isonicotinyl-hydrazone.
    Jeragh B; Ali MS; El-Asmy AA
    Spectrochim Acta A Mol Biomol Spectrosc; 2015 Jun; 145():295-301. PubMed ID: 25791887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and antimycobacterial activity of isoniazid derivatives from renewable fatty acids.
    Rodrigues MO; Cantos JB; D'Oca CR; Soares KL; Coelho TS; Piovesan LA; Russowsky D; da Silva PA; D'Oca MG
    Bioorg Med Chem; 2013 Nov; 21(22):6910-4. PubMed ID: 24103427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and mechanistic investigation of iron(II) complexes of isoniazid and derivatives as a redox-mediated activation strategy for anti-tuberculosis therapy.
    Laborde J; Deraeve C; de Mesquita Vieira FG; Sournia-Saquet A; Rechignat L; Villela AD; Abbadi BL; Macchi FS; Pissinate K; Bizarro CV; Machado P; Basso LA; Pratviel G; de França Lopes LG; Sousa EHS; Bernardes-Génisson V
    J Inorg Biochem; 2018 Feb; 179():71-81. PubMed ID: 29175704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and antitubercular activity of substituted novel pyrazoline derivatives.
    Ali MA; Yar MS; Kumar M; Pandian GS
    Nat Prod Res; 2007 Jun; 21(7):575-9. PubMed ID: 17613813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cuprous complexes formed with isonicotinic hydrazide.
    Krivis AF; Rabb JM
    Science; 1969 May; 164(3883):1064-5. PubMed ID: 4976919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.